Isomannide derivatives as new class of inhibitors for human kallikrein 7.
暂无分享,去创建一个
M. Blaber | L. Juliano | M. Juliano | T. G. Barros | O. Antunes | M. Kondo | S. Pinheiro | E. Muri | R. F. Freitas | L. Puzer | Jorge A. N. Santos | O. Abrahão | Thiago S P Teixeira | J. A. Santos
[1] M. Blaber,et al. Biological evaluation and docking studies of natural isocoumarins as inhibitors for human kallikrein 5 and 7. , 2011, Bioorganic & medicinal chemistry letters.
[2] Tingjun Hou,et al. Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..
[3] A. Longatto-Filho,et al. Analysis of human kallikrein 7 expression as a potential biomarker in cervical neoplasia , 2010, International journal of cancer.
[4] A. Tanuri,et al. Pseudo-peptides derived from isomannide: inhibitors of serine proteases , 2010, Amino Acids.
[5] R. Gallo,et al. The molecular pathology of rosacea. , 2009, Journal of dermatological science.
[6] R. Dauskardt,et al. Effect of corneodesmosome degradation on the intercellular delamination of human stratum corneum. , 2008, The Journal of investigative dermatology.
[7] Christine Humblet,et al. Investigation of MM-PBSA Rescoring of Docking Poses , 2008, J. Chem. Inf. Model..
[8] I. S. Fernández,et al. Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6). , 2008, Journal of molecular biology.
[9] E. Diamandis,et al. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy , 2007, The British journal of dermatology.
[10] A. Krüger,et al. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells , 2006, Biological chemistry.
[11] B. Kuhn,et al. Validation and use of the MM-PBSA approach for drug discovery. , 2005, Journal of medicinal chemistry.
[12] M. G. Albuquerque,et al. N-t-Boc-amino acid esters of isomannide Potential inhibitors of serine proteases , 2004, Amino Acids.
[13] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[14] W. Lubell,et al. Efficient synthesis of enantiopure pyrrolizidinone amino acid. , 2003, The Journal of organic chemistry.
[15] T. Kercher,et al. Efficient, stereoselective synthesis of oxazolo[3,2-a]pyrazin-5-ones: novel bicyclic lactam scaffolds from the bicyclocondensation of 3-aza-1,5-ketoacids and amino alcohols. , 2003, Organic letters.
[16] K. Saijoh,et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. , 2002, The Journal of investigative dermatology.
[17] J. Clements,et al. Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein (KLK) Locus on Proximal 19q13.4* , 2000, The Journal of Biological Chemistry.
[18] P. Nelson,et al. New nomenclature for the human tissue kallikrein gene family. , 2000, Clinical chemistry.
[19] K. Wang,et al. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. , 2000, Gene.
[20] M. Brattsand,et al. Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme. , 1999, The Journal of investigative dermatology.
[21] T. Egelrud,et al. Stratum corneum chymotryptic enzyme in psoriasis , 1999, Archives of Dermatological Research.
[22] A. Ito,et al. Internally quenched fluorogenic protease substrates: Solid-phase synthesis and fluorescence spectroscopy of peptides containing ortho-aminobenzoyl/dinitrophenyl groups as donor-acceptor pairs , 1995, Letters in Peptide Science.
[23] M. Brattsand,et al. A proteolytic cascade of kallikreins in the stratum corneum. , 2005, The Journal of investigative dermatology.